4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D001932:Brain Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004247:DNA / Q000037:antagonists & inhibitors; D006027:Glycosides / Q000494:pharmacology; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008938:Mitosis / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011034:Podophyllotoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D012995:Solubility; D013329:Structure-Activity Relationship; D013876:Thiophenes; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D006027:Glycosides; D013876:Thiophenes; D004247:DNA; D011034:Podophyllotoxin